STOCK TITAN

[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Martin Roper, listed as Director and Chief Executive Officer of Vita Coco Company, Inc. (COCO), reported multiple sales of company common stock under a Rule 10b5-1 trading plan executed on 10/01/2025 and 10/02/2025. The filings show repeated disposals of 5,000-share blocks at weighted average prices in the low $42 range (reported ranges between $41.79 and $42.66). Following the reported 10/01 sale the filing shows 303,897 shares beneficially owned directly; following the 10/02 sale that direct ownership is shown as 298,897. The Form 4 also discloses multiple indirect holdings by related family trusts and a spouse, and reports several non-qualified stock options with exercise prices from $10.178 to $32.78, some fully vested and currently exercisable and others subject to multi-year vesting schedules.

Martin Roper, elencato come Direttore e Amministratore Delegato di Vita Coco Company, Inc. (COCO), ha riportato molteplici vendite di azioni ordinarie della società nell'ambito di un piano di trading Rule 10b5-1 eseguito il 01/10/2025 e il 02/10/2025. Le pratiche indicano cessioni ripetute di blocchi da 5.000 azioni a prezzi medi ponderati nell'intervallo basso di $42 (intervalli riportati tra $41,79 e $42,66). Dopo la vendita riportata il 01/10, la pratica mostra 303.897 azioni detenute direttamente; dopo la vendita del 02/10 quella proprietà diretta è mostrata come 298.897. Il Modulo 4 indica anche molteplici titoli indiretti detenuti da trust familiari correlati e coniuge, e riporta diverse stock option non qualificate con prezzi di esercizio da $10,178 a $32,78, alcune completamente vestite e attualmente esercitabili e altre soggette a piani di vesting pluriennali.

Martin Roper, listado como Director y Chief Executive Officer de Vita Coco Company, Inc. (COCO), informó múltiples ventas de acciones ordinarias de la empresa bajo un plan de negociación Rule 10b5-1 ejecutado el 01/10/2025 y el 02/10/2025. Los archivos muestran disposiciones repetidas de bloques de 5.000 acciones a precios medios ponderados en el rango bajo de $42 (rangos reportados entre $41,79 y $42,66). Tras la venta reportada del 01/10, el archivo muestra 303.897 acciones en propiedad directa; tras la venta del 02/10 esa propiedad directa se muestra como 298.897. El Formulario 4 también divulga múltiples tenencias indirectas por fideicomisos familiares relacionados y un cónyuge, y reporta varias opciones de acciones no calificadas con precios de ejercicio desde $10,178 hasta $32,78, algunas totalmente vestidas y actualmente ejercibles y otras sujetas a planes de vesting plurianuales.

Martin Roper이사CEOVita Coco Company, Inc. (COCO)대표이사로 기재되었으며, Rule 10b5-1 거래 계획에 따라 2025/10/012025/10/02에 실행된 회사 보통주 다수 매도를 보고했습니다. 제출 서류에는 5,000주 단위의 반복 매도가 가중 평균가 $42대 초반의 가격으로 나타나며(보고된 구간은 $41.79 ~ $42.66 사이). 01/10 매도 후 파일은 직접적으로 소유한 주식이 303,897주로 표시되며; 02/10 매도 후에는 이 직접 소유가 298,897주로 표시됩니다. Form 4는 또한 관련 가족 신탁 및 배우자에 의한 다수의 간접 보유를 공개하고, 행사 가격이 $10,178에서 $32.78까지인 다수의 비적격 주식매수선택권을 보고하며, 일부는 이미 완전히 귀속되어 현재 행사 가능하고, 다른 일부는 다년간의 베스팅 일정의 대상이 됩니다.

Martin Roper, répertorié comme Directeur et Chef de la direction de Vita Coco Company, Inc. (COCO), a signalé de multiples ventes d’actions ordinaires de la société dans le cadre d’un plan de trading Rule 10b5-1 exécuté le 01/10/2025 et le 02/10/2025. Les dépôts montrent des cessions répétées de blocs de 5 000 actions à des prix moyens pondérés dans la tranche basse autour de $42 (tranches indiquées entre $41,79 et $42,66). Suite à la vente du 01/10, le dépôt indique 303 897 actions détenues directement; après la vente du 02/10, cette propriété directe est affichée comme 298 897. Le Formulaire 4 divulge également plusieurs avoirs indirects par des fiduciaires familiaux connexes et un conjoint, et rapporte plusieurs options d’achat d’actions non qualifiées avec des prix d’exercice allant de $10,178 à $32,78, dont certaines sont entièrement acquises et exerçables actuellement et d’autres soumises à des plans de vesting pluriannuels.

Martin Roper, aufgeführt als Direktor und Chief Executive Officer von Vita Coco Company, Inc. (COCO), meldete mehrere Verkäufe von Stammaktien des Unternehmens im Rahmen eines Rule 10b5-1-Handelsplans, der am 01.10.2025 und 02.10.2025 ausgeführt wurde. Die Einreichungen zeigen wiederholte Veräußerungen von Blöcken zu je 5.000 Aktien zu gewichteten Durchschnittspreisen im unteren 42 $-Bereich (angegebene Bereiche zwischen $41,79 und $42,66). Nach dem gemeldeten Verkauf vom 01.10. zeigt die Einreichung direkt gehaltene Anteile von 303.897 Aktien; nach dem Verkauf vom 02.10. wird dieses direkte Eigentum als 298.897 angegeben. Das Formular 4 offenbart außerdem mehrere indirekte Beteiligungen durch eng verwandte Trusts und einen Ehepartner, und meldet mehrere nicht qualifizierte Aktienoptionen mit Ausübungspreisen von $10.178 bis $32.78, von denen einige vollständig vestiert und derzeit ausübbar sind und andere Gegenstand mehrjähriger Vesting-Pläne sind.

Martin Roper، المدرج كـمدير والرئيس التنفيذي لشركة Vita Coco Company, Inc. (COCO)، أبلغ عن مبيعات متعددة لأسهم الشركة العادية بموجب خطة تداول Rule 10b5-1 المُنفّذة في 01/10/2025 و02/10/2025. تظهر الملفات عمليات بيع متكررة لشرائح/مجموعة من 5,000 سهم بأسعار متوسطة الوزن في النطاق المنخفض من $42 (النطاقات المدرجة بين $41.79 و $42.66). بعد بيع 01/10، تظهر الملفات ملكية مباشرة من 303,897 سهم؛ وبعد بيع 02/10، يظهر هذا الملكية المباشرة كـ298,897. كما يكشف النموذج 4 عن العديد من الحيازات غير المباشرة من خلال ثقة عائلية مرتبطة وزوج/زوجة، ويرصد عدة خيارات أسهم غير مؤهلة بأسعار ممارسة من $10.178 إلى $32.78، بعضها مكتسب بالكامل وقابل للممارسة حالياً وبعضها خاضع لجداول vesting متعددة السنوات.

Martin Roper,被列为 董事 以及 首席执行官,属于 Vita Coco Company, Inc. (COCO),在一个执行于 2025/10/012025/10/02Rule 10b5-1 交易计划 下,报告了多次出售公司普通股。备案显示多次以 5,000 股为单位的处置,按加权平均价位于 $42 附近的低区间(报告的区间在 $41.79$42.66 之间)。在 01/10 交易后,备案显示直接持有的股份为 303,897 股;在 02/10 交易后,该直接所有权显示为 298,897 股。Form 4 还披露了由相关家庭信托及配偶持有的多项间接持股,并报告若干非合格股票期权,其行权价从 $10.178$32.78,其中一些已完全归属并可立即行使,其他则受多年的 vesting 计划约束。

Positive
  • Sales executed under a Rule 10b5-1 trading plan, indicating predetermined trade instructions rather than ad-hoc insider trades
  • Detailed disclosure of family trust and spouse holdings, improving transparency about indirect beneficial ownership
  • Clear option disclosure with exercise prices and vesting schedules provided for all reported awards
Negative
  • Insider sold multiple blocks of shares on 10/01/2025 and 10/02/2025, reducing direct beneficial ownership from 303,897 to 298,897
  • Weighted average sale prices clustered in the low $42 range, which may be perceived by some investors as material insider selling activity

Insights

CEO/director sales under a 10b5-1 plan, with disclosed family trust holdings.

The Form 4 shows Martin Roper executed multiple sales of 5,000-share blocks on 10/01/2025 and 10/02/2025 under a Rule 10b5-1 plan, with weighted average prices in the low $42 range. That establishes the trades were pre-planned rather than opportunistic.

The filing also discloses indirect holdings through the Christopher G. Roper Exempt Family Trust, the Peter S. Roper Exempt Family Trust, the Thomas L. Roper Exempt Family Trust, and a spouse, which is important for understanding total insider-linked ownership reported on the form.

Significant option positions disclosed; several options are fully vested and exercisable.

Table II lists multiple Non-Qualified Stock Options with exercise prices from $10.178 to $32.78. Footnotes indicate the $10.178 options are fully vested and currently exercisable and other grants vest over specified multi‑year schedules.

The existence of large option grants and current exercisability can affect future share supply if exercised and sold; the Form 4 explicitly quantifies the underlying share counts for each option award.

Martin Roper, elencato come Direttore e Amministratore Delegato di Vita Coco Company, Inc. (COCO), ha riportato molteplici vendite di azioni ordinarie della società nell'ambito di un piano di trading Rule 10b5-1 eseguito il 01/10/2025 e il 02/10/2025. Le pratiche indicano cessioni ripetute di blocchi da 5.000 azioni a prezzi medi ponderati nell'intervallo basso di $42 (intervalli riportati tra $41,79 e $42,66). Dopo la vendita riportata il 01/10, la pratica mostra 303.897 azioni detenute direttamente; dopo la vendita del 02/10 quella proprietà diretta è mostrata come 298.897. Il Modulo 4 indica anche molteplici titoli indiretti detenuti da trust familiari correlati e coniuge, e riporta diverse stock option non qualificate con prezzi di esercizio da $10,178 a $32,78, alcune completamente vestite e attualmente esercitabili e altre soggette a piani di vesting pluriennali.

Martin Roper, listado como Director y Chief Executive Officer de Vita Coco Company, Inc. (COCO), informó múltiples ventas de acciones ordinarias de la empresa bajo un plan de negociación Rule 10b5-1 ejecutado el 01/10/2025 y el 02/10/2025. Los archivos muestran disposiciones repetidas de bloques de 5.000 acciones a precios medios ponderados en el rango bajo de $42 (rangos reportados entre $41,79 y $42,66). Tras la venta reportada del 01/10, el archivo muestra 303.897 acciones en propiedad directa; tras la venta del 02/10 esa propiedad directa se muestra como 298.897. El Formulario 4 también divulga múltiples tenencias indirectas por fideicomisos familiares relacionados y un cónyuge, y reporta varias opciones de acciones no calificadas con precios de ejercicio desde $10,178 hasta $32,78, algunas totalmente vestidas y actualmente ejercibles y otras sujetas a planes de vesting plurianuales.

Martin Roper이사CEOVita Coco Company, Inc. (COCO)대표이사로 기재되었으며, Rule 10b5-1 거래 계획에 따라 2025/10/012025/10/02에 실행된 회사 보통주 다수 매도를 보고했습니다. 제출 서류에는 5,000주 단위의 반복 매도가 가중 평균가 $42대 초반의 가격으로 나타나며(보고된 구간은 $41.79 ~ $42.66 사이). 01/10 매도 후 파일은 직접적으로 소유한 주식이 303,897주로 표시되며; 02/10 매도 후에는 이 직접 소유가 298,897주로 표시됩니다. Form 4는 또한 관련 가족 신탁 및 배우자에 의한 다수의 간접 보유를 공개하고, 행사 가격이 $10,178에서 $32.78까지인 다수의 비적격 주식매수선택권을 보고하며, 일부는 이미 완전히 귀속되어 현재 행사 가능하고, 다른 일부는 다년간의 베스팅 일정의 대상이 됩니다.

Martin Roper, répertorié comme Directeur et Chef de la direction de Vita Coco Company, Inc. (COCO), a signalé de multiples ventes d’actions ordinaires de la société dans le cadre d’un plan de trading Rule 10b5-1 exécuté le 01/10/2025 et le 02/10/2025. Les dépôts montrent des cessions répétées de blocs de 5 000 actions à des prix moyens pondérés dans la tranche basse autour de $42 (tranches indiquées entre $41,79 et $42,66). Suite à la vente du 01/10, le dépôt indique 303 897 actions détenues directement; après la vente du 02/10, cette propriété directe est affichée comme 298 897. Le Formulaire 4 divulge également plusieurs avoirs indirects par des fiduciaires familiaux connexes et un conjoint, et rapporte plusieurs options d’achat d’actions non qualifiées avec des prix d’exercice allant de $10,178 à $32,78, dont certaines sont entièrement acquises et exerçables actuellement et d’autres soumises à des plans de vesting pluriannuels.

Martin Roper, aufgeführt als Direktor und Chief Executive Officer von Vita Coco Company, Inc. (COCO), meldete mehrere Verkäufe von Stammaktien des Unternehmens im Rahmen eines Rule 10b5-1-Handelsplans, der am 01.10.2025 und 02.10.2025 ausgeführt wurde. Die Einreichungen zeigen wiederholte Veräußerungen von Blöcken zu je 5.000 Aktien zu gewichteten Durchschnittspreisen im unteren 42 $-Bereich (angegebene Bereiche zwischen $41,79 und $42,66). Nach dem gemeldeten Verkauf vom 01.10. zeigt die Einreichung direkt gehaltene Anteile von 303.897 Aktien; nach dem Verkauf vom 02.10. wird dieses direkte Eigentum als 298.897 angegeben. Das Formular 4 offenbart außerdem mehrere indirekte Beteiligungen durch eng verwandte Trusts und einen Ehepartner, und meldet mehrere nicht qualifizierte Aktienoptionen mit Ausübungspreisen von $10.178 bis $32.78, von denen einige vollständig vestiert und derzeit ausübbar sind und andere Gegenstand mehrjähriger Vesting-Pläne sind.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Roper Martin

(Last) (First) (Middle)
111 5TH AVENUE
2ND FLOOR

(Street)
NEW YORK NY 10003

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 S(1) 5,000 D $42.457(2) 303,897 D
Common Stock 10/02/2025 S(1) 5,000 D $42.067(3) 298,897 D
Common Stock 10/01/2025 S(1) 5,000 D $42.463(4) 238,406 I by Chris Roper FT(5)
Common Stock 10/02/2025 S(1) 5,000 D $42.049(6) 233,406 I by Chris Roper FT(5)
Common Stock 10/01/2025 S(1) 5,000 D $42.458(7) 237,515 I by Peter Roper FT(8)
Common Stock 10/02/2025 S(1) 5,000 D $42.066(9) 232,515 I by Peter Roper FT(8)
Common Stock 10/01/2025 S(1) 5,000 D $42.467(10) 238,531 I by Thomas Roper FT(11)
Common Stock 10/02/2025 S(1) 5,000 D $42.069(12) 233,531 I by Thomas Roper FT(11)
Common Stock 61,200 I by Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $10.178 (13) 09/19/2029 Common Stock 579,670 579,670 D
Non-Qualified Stock Option (right to buy) $10.178 (14) 01/11/2031 Common Stock 40,950 40,950 D
Non-Qualified Stock Option (right to buy) $15 (15) 10/21/2031 Common Stock 298,507 298,507 D
Non-Qualified Stock Option (right to buy) $16.91 (16) 03/10/2033 Common Stock 46,875 46,875 D
Non-Qualified Stock Option (right to buy) $26.18 (17) 03/04/2034 Common Stock 62,743 62,743 D
Non-Qualified Stock Option (right to buy) $32.78 (18) 03/03/2035 Common Stock 70,715 70,715 D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.23 to $42.66, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.23 to $42.66, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
5. These shares are held by the Christopher G. Roper Exempt Family Trust.
6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.23 to $42.66, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
8. These shares are held by the Peter S. Roper Exempt Family Trust.
9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.23 to $42.66, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
11. These shares are held by the Thomas L. Roper Exempt Family Trust.
12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
13. The stock option is fully vested and currently exercisable.
14. The stock option is fully vested and currently exercisable.
15. The stock option vests in four equal annual installments beginning on November 27, 2022.
16. The stock option vests in four equal annual installments beginning on March 10, 2024.
17. The stock option vests in four equal annual installments beginning on March 4, 2025.
18. The Stock Option vests in four equal annual installments beginning in March 3, 2026.
By: Alison Klein, Attorney-in-Fact For: Martin Roper 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Martin Roper (COCO) report on this Form 4?

Martin Roper reported multiple sales of common stock on 10/01/2025 and 10/02/2025 under a Rule 10b5-1 trading plan, in 5,000-share blocks at weighted average prices in the low $42 range.

How many shares did Martin Roper own after these transactions?

The filing shows 303,897 shares held directly after the 10/01/2025 sale and 298,897 held directly after the 10/02/2025 sale.

Are any of Martin Roper's stock options exercisable now?

Yes; the Form 4 discloses Non-Qualified Stock Options at an exercise price of $10.178 that are fully vested and currently exercisable, and other option grants with specified vesting schedules.

Did the Form 4 disclose indirect holdings by family trusts?

Yes; the filing identifies shares held indirectly by the Christopher G. Roper Exempt Family Trust, Peter S. Roper Exempt Family Trust, Thomas L. Roper Exempt Family Trust, and a spouse.

Were the sale prices single prices or ranges?

The filing reports weighted average prices and specifies the sales occurred across price ranges between $41.79 and $42.66.
Vita Coco Company, Inc.

NASDAQ:COCO

COCO Rankings

COCO Latest News

COCO Latest SEC Filings

COCO Stock Data

2.42B
50.75M
10.67%
85.62%
8.23%
Beverages - Non-Alcoholic
Beverages
Link
United States
NEW YORK